BOE information is required for certain Medicare Part B products, mainly specific diabetes‑related supplies rather than all Part B drugs or devices.

What “BOE information” means

  • BOE stands for Beneficiary Obligation Explanation , a documentation element used in some Medicare Part B billing and training materials.
  • It is tied to when and why a beneficiary may have a financial responsibility for a product, especially for supplies that have strict usage and coverage rules.

Products that require BOE information

When this question appears in Medicare Part B training or quizzes, the products that require BOE information are:

  • Diabetic testing strips and lancets
    • These are Part B‑covered supplies with utilization limits (e.g., number of strips per time period) and specific medical-necessity requirements, so extra documentation and explanation of the beneficiary’s obligations are emphasized.
  • Continuous glucose sensors and transmitters
    • As components of continuous glucose monitoring (CGM) systems, these fall under more complex coverage criteria, so BOE information is called out in training to ensure correct billing and beneficiary cost‑share communication.

Some sources list insulin used in a tubed insulin pump together with diabetic supplies in this context, but the core consistently‑flagged categories for BOE information are diabetic testing strips/lancets and CGM sensors/transmitters.

Products that typically do not require BOE information

  • Respiratory drugs used in a nebulizer
    • These can be covered under Medicare Part B but are not usually singled out as requiring BOE information in the common training question variants.
  • Other Part B drugs and supplies
    • Many other covered products do not appear in the standard “BOE information is required on which types of products” question, which is narrowly focused on diabetes testing supplies and CGM‑related items.

Mini FAQ

  • Is BOE used for all diabetes products?
    No. The training questions focus on testing strips/lancets and CGM sensors/transmitters , not every diabetes‑related medication or device.
  • Why are these products singled out?
    Because they have stricter coverage rules, quantity limits, and documentation requirements, so staff need to clearly document and explain beneficiary responsibility.

Information gathered from public forums or data available on the internet and portrayed here.